Perspectives on Spinal Manipulative Therapy for Low Back Pain

January 8, 2026 updated by: University of Florida

Patient and Physical Therapist Perspectives on Spinal Manipulative Therapy for Low Back Pain

The goal of this study is to better understand how the thoughts and beliefs of patients with low back pain and their physical therapist influence how much patients benefit from physical therapy. Participants will receive physical therapy as determined by their physical therapist including spinal manipulative therapy, exercise, and education. Participants with low back pain and their physical therapists will complete forms about their thoughts and beliefs about low back pain and treatment.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32610
        • Recruiting
        • University of Florida
        • Principal Investigator:
          • Joel E Bialosky, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Pain between 12th rib and buttocks with or without symptoms into one or both legs, which, in the opinion of the examiner, originate from the lumbar region.
  • Meets NIH Task Force criteria for chronic low back pain

Exclusion Criteria:

  • Prior surgery to the lumbosacral spine
  • Currently pregnant
  • Not currently receiving spinal manipulative therapy or exercise interventions from another healthcare provider such as a chiropractor or massage therapist.
  • No neurogenic signs indicating radiculopathy
  • No "red flags" of a potentially serious condition (e.g., cauda equina syndrome, fracture, cancer, infection, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Patients
Patients seeking physical therapy for low back pain
Patients with low back pain will receive a combination of education, spinal manipulative therapy, and exercise as prescribed by their physical therapist
Other: Physical therapists
Physical therapists treating enrolled patients
Physical therapists will provide a combination of education, spinal manipulative therapy, and exercise to their patients with low back pain participating in the study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROMIS-29
Time Frame: Baseline and 2 weeks and 6 weeks and 12 weeks and 18 weeks and 26 weeks
Assesses pain intensity using a single item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) using four items per domain. This will only be completed by patient participants in the study.
Baseline and 2 weeks and 6 weeks and 12 weeks and 18 weeks and 26 weeks
NIH Chronic LBP Impact Score
Time Frame: 12 weeks and 26 weeks
Combines results of the Pain Intensity, Physical Function, and Pain Interference PROMIS scores. Scores range from 8 (least impact) to 50 (greatest impact).
12 weeks and 26 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Acceptable Symptom State
Time Frame: Baseline and 2 weeks and 6 weeks and 12 weeks and 18 weeks and 26 weeks
The PASS is a self-report, single item question asking: "Taking into account the many ways your pain affects your daily life, if you were to remain for the next few months as you are now, would you consider your current state to be satisfactory?" with response options being 'Yes' or 'No'. Only patient participants will complete this assessment.
Baseline and 2 weeks and 6 weeks and 12 weeks and 18 weeks and 26 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Low Back Pain Treatment Beliefs Questionnaire
Time Frame: Baseline and 2 weeks
Assesses perceived credibility, effectiveness, concerns, and individual fit for treatments including medication, exercise, spinal manipulation, spinal mobilization, and massage. Both participating patients and physical therapists will complete this questionnaire.
Baseline and 2 weeks
The Credibility Expectancy Questionnaire
Time Frame: Baseline and 2 weeks
The Credibility Expectancy Questionnaire will assess credibility and expectancy of SMT in terms of three items related to credibility (how logical therapy offered seems) and three items related to expectancy (expectations for treatment to reduce symptoms). Both participating patients and physical therapists will complete the Credibility Expectancy Questionnaire.
Baseline and 2 weeks
The Back Pain Attitudes Questionnaire
Time Frame: Baseline and 2 weeks (patients); Baseline only (physical therapists)
This will assess the beliefs about low back pain of participating patients and their physical therapists
Baseline and 2 weeks (patients); Baseline only (physical therapists)
The Optimal Screening for Prediction of Referral and Outcome Yellow Flag Tool
Time Frame: Baseline and 2 weeks and 6 weeks and 12 weeks
A multidimensional tool used for assessment of pain-related psychological characteristics for people with musculoskeletal pain conditions. The OSPRO-YF evaluates discrete pain-related psychological characteristics across 3 constructs: (1) negative mood (anxiety, depression, and anger); (2) fear-avoidance (pain catastrophizing, fear avoidance (work and physical activity), pain anxiety, and kinesiophobia); and (3) positive affect/coping (pain self-efficacy, self-efficacy for rehabilitation, and pain acceptance). Only participating patients will complete this questionnaire.
Baseline and 2 weeks and 6 weeks and 12 weeks
The Working Alliance Inventory Short Revised Therapist Versions
Time Frame: 2 weeks and 6 weeks
Assesses therapeutic alliance from the physical therapist perspective. Only participating physical therapists will complete this assessment.
2 weeks and 6 weeks
The Working Alliance Inventory Short Revised Client Versions
Time Frame: 2 weeks and 6 weeks
Assesses therapeutic alliance from the patientt perspective. Only participating patients will complete this assessment.
2 weeks and 6 weeks
Patient Acceptable Symptom State
Time Frame: Baseline and 2 weeks and 6 weeks and 12 weeks and 18 weeks and 26 weeks
The PASS is a self-report, single item question asking: "Taking into account the many ways your pain affects your daily life, if you were to remain for the next few months as you are now, would you consider your current state to be satisfactory?" with response options being 'Yes' or 'No'. Only patient participants will complete this assessment.
Baseline and 2 weeks and 6 weeks and 12 weeks and 18 weeks and 26 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 17, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

September 6, 2024

First Submitted That Met QC Criteria

September 6, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

January 12, 2026

Last Update Submitted That Met QC Criteria

January 8, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Physical therapy

Subscribe